Product Introduction:
Acris 25 mg Injection contains Zoledronic Acid, a bisphosphonate class drug used to manage hypercalcemia of malignancy (high blood calcium due to cancer) and to prevent or reduce bone complications in patients with multiple myeloma or bone metastases from solid tumors. It works by slowing down bone loss and reducing calcium release into the blood.
Uses:
-
Hypercalcemia of malignancy
-
Bone metastases from cancers such as breast, prostate, and lung cancer
-
Multiple myeloma-related bone damage
-
Osteolytic bone lesions in cancer patients
Benefits:
-
Lowers elevated calcium levels in the blood
-
Strengthens bones weakened by cancer
-
Reduces the risk of fractures and other skeletal-related events
-
Helps control bone pain in metastatic disease
Composition:
-
Zoledronic Acid 25 mg per vial (1 ml)
Side Effects:
-
Fever or flu-like symptoms
-
Fatigue
-
Nausea or vomiting
-
Joint or muscle pain
-
Hypocalcemia (low calcium levels)
-
Kidney dysfunction (monitoring required)
-
Rare: Osteonecrosis of the jaw
Safety Advice:
-
Administration: For hospital use only; must be given by a healthcare professional via IV infusion
-
Hydration: Ensure adequate hydration before infusion
-
Kidney Function: Monitor renal parameters before and during treatment
-
Calcium & Vitamin D: Supplementation may be recommended to prevent hypocalcemia
-
Pregnancy/Breastfeeding: Not recommended unless prescribed by an oncologist
-
Dental Check: Dental exam recommended before starting therapy to avoid jaw complications
